Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C021296 |
2-ethoxyethanol |
2-ethoxyethanol results in increased expression of IGF2 mRNA | increases expression | 19643169
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane affects the expression of IGF2 mRNA | affects expression | 18648102
|
C002202 |
4-oxoretinoic acid |
4-oxoretinoic acid results in decreased expression of IGF2 mRNA | decreases expression | 15982314
|
C032311 |
aluminum fluoride |
aluminum fluoride results in increased expression of IGF2 mRNA | increases expression | 11996908
|
C032311 |
aluminum fluoride |
aluminum fluoride results in increased expression of IGF2 protein | increases expression | 11996908
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of IGF2 mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of IGF2 mRNA | increases expression | 20382639
|
C095105 |
bexarotene |
bexarotene results in increased expression of IGF2 mRNA | increases expression | 16648578
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of IGF2 mRNA | decreases expression | 20505776
|
D019819 |
Budesonide |
Budesonide inhibits the reaction [vinyl carbamate results in decreased methylation of IGF2 protein] | decreases methylation|decreases reaction | 15824018
|
D002118 |
Calcium |
Cobalt inhibits the reaction [IGF2 protein results in increased import of Calcium] | decreases reaction|increases import | 2442157 2539779
|
D002118 |
Calcium |
[IGF2 protein co-treated with EGF protein] results in increased import of Calcium | affects cotreatment|increases import | 2442157
|
D002118 |
Calcium |
IGF2 protein results in increased import of Calcium | increases import | 2442157 2460452 2539779
|
D002118 |
Calcium |
Lanthanum inhibits the reaction [IGF2 protein results in increased import of Calcium] | decreases reaction|increases import | 2442157
|
D002118 |
Calcium |
Pertussis Toxin inhibits the reaction [IGF2 protein results in increased import of Calcium] | decreases reaction|increases import | 2442157
|
D002118 |
Calcium |
tetramethrin inhibits the reaction [IGF2 protein results in increased import of Calcium] | decreases reaction|increases import | 2442157 2539779
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of IGF2 mRNA | increases expression | 11566570
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of IGF2 mRNA | increases expression | 17032414
|
D002794 |
Choline |
Choline results in increased expression of IGF2 mRNA | increases expression | 17264169
|
D002794 |
Choline |
Choline results in increased expression of IGF2 protein | increases expression | 17264169
|
D003035 |
Cobalt |
Cobalt inhibits the reaction [IGF2 protein results in increased import of Calcium] | decreases reaction|increases import | 2539779 2442157
|
C014347 |
decitabine |
decitabine inhibits the reaction [tobacco tar results in decreased expression of IGF2 mRNA] | decreases expression|decreases reaction | 19559774
|
D003907 |
Dexamethasone |
Dexamethasone inhibits the reaction [nitrofen results in increased expression of IGF2 mRNA] | decreases reaction|increases expression | 10370016
|
D003907 |
Dexamethasone |
Dexamethasone inhibits the reaction [nitrofen results in increased expression of IGF2 protein] | decreases reaction|increases expression | 10370016
|
D003993 |
Dibutyl Phthalate |
Dibutyl Phthalate results in increased expression of IGF2 mRNA | increases expression | 15829613
|
D003999 |
Dichloroacetate |
Dichloroacetate results in decreased methylation of IGF2 gene | decreases methylation | 15036762
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine affects the expression of IGF2 mRNA | affects expression | 20387270
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of IGF2 mRNA | decreases expression | 19542621
|
D004054 |
Diethylstilbestrol |
[Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of IGF2 mRNA | affects cotreatment|increases expression | 19665456
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in increased expression of IGF2 mRNA | increases expression | 17032414
|
C010452 |
estradiol-17 beta-benzoate |
estradiol-17 beta-benzoate affects the expression of IGF2 mRNA | affects expression | 15059950
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of IGF2 mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol promotes the reaction [resveratrol results in decreased secretion of IGF2 protein] | decreases secretion|increases reaction | 16037384
|
D004958 |
Estradiol |
Estradiol results in increased expression of IGF2 mRNA | increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased secretion of IGF2 protein | increases secretion | 16037384
|
D004958 |
Estradiol |
resveratrol inhibits the reaction [Estradiol results in increased secretion of IGF2 protein] | decreases reaction|increases secretion | 16037384
|
D004958 |
Estradiol |
Tamoxifen inhibits the reaction [Estradiol results in increased secretion of IGF2 protein] | decreases reaction|increases secretion | 16037384
|
D004967 |
Estrogens |
Estrogens results in increased expression of IGF2 mRNA | increases expression | 14669216
|
D004967 |
Estrogens |
Tetrachlorodibenzodioxin inhibits the reaction [Estrogens results in increased expression of IGF2 mRNA] | decreases reaction|increases expression | 14669216
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of IGF2 mRNA | decreases expression | 16872691
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of IGF2 protein | increases expression | 15817916
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of IGF2 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of IGF2 mRNA | decreases expression | 15576828 15834898 17557909
|
C053629 |
fluoroaluminum |
fluoroaluminum results in increased expression of IGF2 mRNA | increases expression | 11996908
|
C053629 |
fluoroaluminum |
fluoroaluminum results in increased expression of IGF2 protein | increases expression | 11996908
|
D005620 |
Freund's Adjuvant |
Freund's Adjuvant inhibits the reaction [Urethane affects the expression of IGF2 mRNA] | affects expression|decreases reaction | 12810352
|
D005620 |
Freund's Adjuvant |
[Urethane co-treated with Freund's Adjuvant] results in increased expression of IGF2 mRNA | affects cotreatment|increases expression | 12400877
|
D007811 |
Lanthanum |
Lanthanum inhibits the reaction [IGF2 protein results in increased import of Calcium] | decreases reaction|increases import | 2442157
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of IGF2 mRNA | decreases expression | 12057914
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of IGF2 mRNA | increases expression | 16448778
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of IGF2 protein | increases expression | 16448778
|
D008070 |
Lipopolysaccharides |
Tretinoin inhibits the reaction [Lipopolysaccharides results in increased expression of IGF2 mRNA] | decreases reaction|increases expression | 16448778
|
D008070 |
Lipopolysaccharides |
Tretinoin inhibits the reaction [Lipopolysaccharides results in increased expression of IGF2 protein] | decreases reaction|increases expression | 16448778
|
C005219 |
methyl cellosolve |
methyl cellosolve results in increased expression of IGF2 mRNA | increases expression | 19643169
|
C007350 |
nitrofen |
Dexamethasone inhibits the reaction [nitrofen results in increased expression of IGF2 mRNA] | decreases reaction|increases expression | 10370016
|
C007350 |
nitrofen |
Dexamethasone inhibits the reaction [nitrofen results in increased expression of IGF2 protein] | decreases reaction|increases expression | 10370016
|
C007350 |
nitrofen |
nitrofen results in increased expression of IGF2 mRNA | increases expression | 10370016
|
C007350 |
nitrofen |
nitrofen results in increased expression of IGF2 protein | increases expression | 10370016
|
D019308 |
Palmitic Acid |
Palmitic Acid results in increased expression of IGF2 mRNA | increases expression | 17658692
|
D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [IGF2 protein results in increased import of Calcium] | decreases reaction|increases import | 2442157
|
D010672 |
Phenytoin |
Phenytoin results in increased expression of IGF2 mRNA | increases expression | 9988880
|
C025299 |
polyphenols |
polyphenols results in decreased expression of IGF2 mRNA | decreases expression | 16293270
|
D020849 |
Raloxifene |
Raloxifene results in increased expression of IGF2 mRNA | increases expression | 15576828
|
C059514 |
resveratrol |
Estradiol promotes the reaction [resveratrol results in decreased secretion of IGF2 protein] | decreases secretion|increases reaction | 16037384
|
C059514 |
resveratrol |
resveratrol affects the expression of IGF2 mRNA | affects expression | 16393696 16037384
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [Estradiol results in increased secretion of IGF2 protein] | decreases reaction|increases secretion | 16037384
|
C059514 |
resveratrol |
resveratrol results in decreased secretion of IGF2 protein | decreases secretion | 16037384
|
C059514 |
resveratrol |
resveratrol results in increased expression of and results in increased secretion of IGF2 protein | increases expression|increases secretion | 16037384
|
C059514 |
resveratrol |
resveratrol results in increased expression of IGF2 protein | increases expression | 16393696
|
C059514 |
resveratrol |
[resveratrol results in increased expression of IGF2 protein] which results in increased secretion of CTSD protein | increases expression|increases secretion | 16393696
|
C059514 |
resveratrol |
Tamoxifen inhibits the reaction [resveratrol results in increased secretion of IGF2 protein] | decreases reaction|increases secretion | 16037384
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of IGF2 mRNA | increases expression | 12016162
|
C017947 |
sodium arsenite |
[Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of IGF2 mRNA | affects cotreatment|increases expression | 19665456
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of IGF2 mRNA | affects expression | 16507464
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of IGF2 mRNA | decreases expression | 17451858
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of IGF2 mRNA | increases expression | 17077188
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of IGF2 mRNA | decreases expression | 16876216
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of IGF2 mRNA | increases expression | 11241755
|
D013629 |
Tamoxifen |
Tamoxifen inhibits the reaction [Estradiol results in increased secretion of IGF2 protein] | decreases reaction|increases secretion | 16037384
|
D013629 |
Tamoxifen |
Tamoxifen inhibits the reaction [resveratrol results in increased secretion of IGF2 protein] | decreases reaction|increases secretion | 16037384
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased secretion of IGF2 protein | decreases secretion | 16037384
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of IGF2 mRNA | affects expression | 17555576
|
D013739 |
Testosterone |
Testosterone results in decreased expression of IGF2 protein | decreases expression | 15817916
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of IGF2 mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of IGF2 mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of IGF2 mRNA | increases expression | 15056799
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of IGF2 mRNA | decreases expression | 14960483
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased methylation of IGF2 gene | increases methylation | 14960483
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [Estrogens results in increased expression of IGF2 mRNA] | decreases reaction|increases expression | 14669216
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased methylation of IGF2 gene | decreases methylation | 17407073
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of IGF2 mRNA | increases expression | 17407073
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of IGF2 protein | increases expression | 17407073
|
C009424 |
tetramethrin |
tetramethrin inhibits the reaction [IGF2 protein results in increased import of Calcium] | decreases reaction|increases import | 2442157 2539779
|
D013853 |
Thioacetamide |
Thioacetamide results in increased expression of IGF2 mRNA | increases expression | 17997003
|
C402769 |
tipifarnib |
tipifarnib results in increased expression of IGF2 mRNA | increases expression | 16403772
|
C024746 |
tobacco tar |
decitabine inhibits the reaction [tobacco tar results in decreased expression of IGF2 mRNA] | decreases expression|decreases reaction | 19559774
|
C024746 |
tobacco tar |
tobacco tar results in decreased expression of IGF2 mRNA | decreases expression | 19559774
|
D014212 |
Tretinoin |
Tretinoin metabolite results in increased expression of IGF2 mRNA | increases expression | 15982314
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [IGF2R binds to and results in increased secretion of IGF2 protein modified form] | affects binding|increases reaction|increases secretion | 16680587
|
D014212 |
Tretinoin |
Tretinoin results in decreased activity of IGF2 protein | decreases activity | 16680587
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of IGF2 mRNA | increases expression | 16604517
|
D014212 |
Tretinoin |
Tretinoin inhibits the reaction [Lipopolysaccharides results in increased expression of IGF2 mRNA] | decreases reaction|increases expression | 16448778
|
D014212 |
Tretinoin |
Tretinoin inhibits the reaction [Lipopolysaccharides results in increased expression of IGF2 protein] | decreases reaction|increases expression | 16448778
|
D014238 |
Trichloroacetic Acid |
Trichloroacetic Acid results in decreased methylation of IGF2 gene | decreases methylation | 15036762
|
D014520 |
Urethane |
Freund's Adjuvant inhibits the reaction [Urethane affects the expression of IGF2 mRNA] | affects expression|decreases reaction | 12810352
|
D014520 |
Urethane |
IFNG protein promotes the reaction [Urethane results in increased expression of IGF2 mRNA] | increases expression|increases reaction | 12810352
|
D014520 |
Urethane |
[Urethane co-treated with Freund's Adjuvant] results in increased expression of IGF2 mRNA | affects cotreatment|increases expression | 12400877
|
C025643 |
vinclozolin |
vinclozolin affects the expression of IGF2 mRNA | affects expression | 19015723
|
C017963 |
vinyl carbamate |
Budesonide inhibits the reaction [vinyl carbamate results in decreased methylation of IGF2 protein] | decreases methylation|decreases reaction | 15824018
|
C017963 |
vinyl carbamate |
vinyl carbamate results in decreased expression of IGF2 mRNA | decreases expression | 17849452
|
C017963 |
vinyl carbamate |
vinyl carbamate results in decreased methylation of IGF2 protein | decreases methylation | 15824018
|
D002762 |
Cholecalciferol |
Cholecalciferol results in increased expression of IGF2 mRNA | increases expression | 17170073
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.01 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
2-ethoxyethanol |
16.19 | 7151721 6499820 6499796 6499823 6499812 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
methyl cellosolve |
16.19 | 6499812 6474471 3652986 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenytoin |
16.19 | 9118846 3425630 6195326 9677735 10563481 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
16.19 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.03 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.40 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.38 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.55 | 11850527 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
11.83 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
11.83 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
11.83 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Urethane |
11.83 | 18316556 |
MESH:D000230 |
Adenocarcinoma |
|
vinyl carbamate |
11.83 | 16247444 17363558 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Urethane |
5.17 | 15814487 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
17.60 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
17.60 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
17.60 | 19555203 |
MESH:D000236 |
Adenoma |
|
resveratrol |
17.60 | 15688382 |
MESH:D000236 |
Adenoma |
|
Urethane |
17.60 | 6695378 10530776 16926031 17093202 10822126 17195641 11497255 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
14.52 | 17620307 17162532 19061943 18056438 19052882 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
14.52 | 16835633 |
MESH:D018248 |
Adenoma, Liver Cell |
|
vinyl carbamate |
14.52 | 12371669 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.16 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.36 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.09 | 17451421 17308373 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.19 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
3.93 | 15800139 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
3.93 | 16162502 16183991 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.98 | 15469931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.49 | 11748828 |
MESH:D000748 |
Anemia, Macrocytic |
|
methyl cellosolve |
5.81 | 3699323 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
5.32 | 7506515 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.22 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
2.95 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
14.73 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
14.73 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
14.73 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
14.73 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.12 | 16292516 |
MESH:D053627 |
Asthenozoospermia |
|
2-ethoxyethanol |
10.85 | 10689203 6499823 6499807 |
MESH:D053627 |
Asthenozoospermia |
|
methyl cellosolve |
10.85 | 3987992 |
MESH:D001249 |
Asthma |
|
Budesonide |
4.82 | 10893010 20004779 18489783 15572850 12604023 15136378 12113382 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.82 | 16456186 |
MESH:D001259 |
Ataxia |
|
2-ethoxyethanol |
4.97 | 7151721 |
MESH:D050197 |
Atherosclerosis |
|
Phenytoin |
6.04 | 15136057 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.04 | 16873680 17967414 |
MESH:D001284 |
Atrophy |
|
2-ethoxyethanol |
9.74 | 6499799 15850284 |
MESH:D001284 |
Atrophy |
|
methyl cellosolve |
9.74 | 2626667 6705890 3699323 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 17547689 |
MESH:D001321 |
Autistic Disorder |
|
Choline |
3.42 | 16818868 |
MESH:D001327 |
Autoimmune Diseases |
|
Cholecalciferol |
4.52 | 16142846 |
MESH:D053713 |
Azoospermia |
|
2-ethoxyethanol |
5.06 | 6499807 6492198 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.90 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.48 | 11289319 1440618 |
MESH:D001724 |
Birth Weight |
|
2-ethoxyethanol |
5.97 | 2884743 6499823 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
12.67 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Thioacetamide |
12.67 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
12.67 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
2-ethoxyethanol |
10.24 | 6499796 7151721 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
10.24 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.41 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
8.38 | 11985600 |
MESH:D001862 |
Bone Resorption |
|
Freund's Adjuvant |
8.38 | 16769263 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
3.96 | 16580743 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.76 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
10.08 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
10.08 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Cobalt |
10.08 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
10.08 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
10.08 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
10.08 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
10.08 | 12948864 19861407 17289903 16675129 17261762 18497071 14630087 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
10.08 | 17049068 16837676 17893378 17595753 16912660 17952589 15572757 15775269 15758505 17440819 17242785 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
10.08 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
10.08 | 20005174 19142967 19410462 19155303 21152245 19189210 16873071 11161223 17242785 18629630 17440819 16202921 15565566 19084267 20859285 15668708 18425577 19011961 17261762 20135344 16273361 18351453 19487384 19189212 19288272 18855134 21138602 17893378 19059307 19115204 18997820 20544844 18821012 18815881 19244106 19221464 19066611 18984771 19289846 20390343 17049068 19200415 20065188 19103187 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
10.08 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
10.08 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
10.08 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.06 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.93 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.27 | 16050911 15700767 10355542 15721981 3786805 15673190 18705752 16227642 16097048 16011737 16192424 16124888 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
6.96 | 19555203 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
6.96 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.99 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.62 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
26.49 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
26.49 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
26.49 | 10737359 16502159 16807293 17055752 20524982 3084413 18665156 19171122 19418558 16935385 18785209 10672840 21159647 17173139 20084675 19052882 19335982 19208518 19394651 18210153 3581430 17761372 18978308 20512989 18691550 18506893 19519916 16288022 16681979 17138121 19822196 19701751 18056438 16328049 11831363 19539802 20432363 18788625 20007298 19919837 20935162 17978847 18971187 20514400 16779866 16569478 17428255 18393292 19107877 16878318 19383236 20214788 16830150 20727157 16540662 20101231 17162532 18494052 16698587 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
26.49 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
26.49 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estrogens |
26.49 | 15341023 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
26.49 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
26.49 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
26.49 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thioacetamide |
26.49 | 17997003 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
26.49 | 1917145 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
vinyl carbamate |
26.49 | 12371669 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.46 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.06 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
5.58 | 16247446 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
vinyl carbamate |
5.58 | 16247446 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.41 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
12.37 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
12.37 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
12.37 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
12.37 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
12.37 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
7.97 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
7.97 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.06 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
6.32 | 15775269 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.32 | 15458977 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.77 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
21.51 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
21.51 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
21.51 | 17174075 2727394 7505956 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
21.51 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
21.51 | 20056578 19524636 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
tobacco tar |
21.51 | 19559774 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenytoin |
4.78 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.06 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
3.46 | 20678186 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
13.54 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
13.54 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thioacetamide |
13.54 | 18291259 |
MESH:D002764 |
Cholecystitis |
|
2-ethoxyethanol |
11.86 | 6499794 |
MESH:D002764 |
Cholecystitis |
|
methyl cellosolve |
11.86 | 6499794 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
6.54 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.54 | 17110522 17681005 15861022 16919318 17333356 16105132 11677210 |
OMIM:601042 |
CHOREOATHETOSIS/SPASTICITY, EPISODIC |
|
Phenytoin |
5.34 | 11748493 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.62 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Phenytoin |
3.86 | 2227380 |
MESH:D002972 |
Cleft Palate |
|
Phenytoin |
12.12 | 10789828 6862529 1687470 3877104 6856622 2227380 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
12.12 | 15668235 15340226 16354765 8697196 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
12.12 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
Urethane |
12.12 | 12810352 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.10 | 15800139 |
MESH:D003092 |
Colitis |
|
resveratrol |
7.92 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
7.92 | 17035595 |
MESH:D003103 |
Coloboma |
|
Phenytoin |
4.68 | 9212184 |
MESH:D003110 |
Colonic Neoplasms |
marker/mechanism |
|
| 15057734 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
7.30 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
7.30 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
7.30 | 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
7.30 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.56 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.56 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
methyl cellosolve |
13.15 | 12530607 6499821 |
MESH:D000013 |
Congenital Abnormalities |
|
Phenytoin |
13.15 | 10627286 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
13.15 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.40 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
8.47 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dichloroacetate |
8.47 | 15736158 |
MESH:D019465 |
Craniofacial Abnormalities |
|
nitrofen |
8.47 | 11405365 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Phenytoin |
8.47 | 8986270 19952982 9212184 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
8.47 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
8.47 | 9664655 17551590 14991402 10589399 9211117 16925845 9125849 8800419 9224671 9142499 |
MESH:D016638 |
Critical Illness |
|
Estrogens |
5.42 | 16670151 |
MESH:D003456 |
Cryptorchidism |
|
Dibutyl Phthalate |
16.46 | 16037377 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
16.46 | 16002989 12952375 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
16.46 | 14966744 |
MESH:D003643 |
Death |
|
2-ethoxyethanol |
5.43 | 6499796 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.85 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.72 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
5.38 | 12868966 8970840 8156756 2524372 18759878 14531868 11298694 11906362 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
5.38 | 12438553 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.01 | 2952479 3621924 |
MESH:D002658 |
Developmental Disabilities |
|
Choline |
4.31 | 16818868 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.34 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
3.69 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
3.69 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
17.78 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
17.78 | 17451421 15920148 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
17.78 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
17.78 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.21 | 7237001 |
OMIM:607208 |
DRAVET SYNDROME |
|
Phenytoin |
4.87 | 11748493 |
MESH:D003875 |
Drug Eruptions |
|
Phenytoin |
4.98 | 15024534 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
15.76 | 18289764 9328219 18692083 8291058 1440618 16192314 6482804 11289319 18648102 9653073 9022650 7440962 6679447 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
15.76 | 16177239 15968718 19085960 2869522 15998439 17522070 7120509 16227642 19336974 10915739 7440962 21278145 11566570 4309450 7179309 9327722 15027814 6623471 3786805 6884620 10092053 3732212 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
15.76 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
15.76 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
15.76 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
15.76 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Thioacetamide |
15.76 | 12963478 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.36 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Budesonide |
5.01 | 20016425 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.96 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
12.66 | 19703484 |
MESH:D004487 |
Edema |
|
Raloxifene |
12.66 | 15860553 |
MESH:D004487 |
Edema |
|
resveratrol |
12.66 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.66 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.15 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.15 | 18230668 |
MESH:D020964 |
Embryo Loss |
|
2-ethoxyethanol |
5.97 | 6499796 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
23.44 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Phenytoin |
23.44 | 17654737 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
23.44 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
23.44 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
23.44 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.58 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
4.16 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
14.84 | 15700306 16804899 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
14.84 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
14.84 | 19155303 20544844 16202921 17893378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
14.84 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.57 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
3.87 | 17637181 15328337 15821434 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.33 | 17923197 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Phenytoin |
4.70 | 20235791 |
MESH:D004820 |
Epidermolysis Bullosa |
|
Phenytoin |
5.69 | 1399206 6251365 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenytoin |
4.38 | 11558140 17116037 |
MESH:D004827 |
Epilepsy |
|
Phenytoin |
3.65 | 821787 11434505 20417680 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenytoin |
4.78 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenytoin |
4.54 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.58 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.33 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.33 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
6.33 | 17016578 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.50 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.50 | 16938888 9664655 |
MESH:D005218 |
Fat Necrosis |
|
Thioacetamide |
5.18 | 16456712 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
19.67 | 15959796 61145 12795759 19224547 12631006 17595544 16239168 16045604 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
19.67 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
19.67 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
19.67 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
19.67 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
7.09 | 16534752 16513791 16002989 16611131 15751030 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
7.09 | 16709447 |
MESH:D005313 |
Fetal Death |
|
2-ethoxyethanol |
15.20 | 6499823 7198755 6499820 7151721 2884743 |
MESH:D005313 |
Fetal Death |
|
Phenytoin |
15.20 | 10627286 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
15.20 | 11858732 |
MESH:D005317 |
Fetal Growth Retardation |
|
2-ethoxyethanol |
4.91 | 6499796 |
MESH:D005327 |
Fetal Resorption |
|
2-ethoxyethanol |
10.88 | 6499812 6499820 |
MESH:D005327 |
Fetal Resorption |
|
methyl cellosolve |
10.88 | 6474471 6499812 6499821 3987992 |
MESH:D020567 |
Fetal Weight |
|
2-ethoxyethanol |
11.86 | 7151721 2884743 6499820 |
MESH:D020567 |
Fetal Weight |
|
methyl cellosolve |
11.86 | 6474471 6499812 6499821 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.56 | 11852909 9205823 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.48 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.00 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.65 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
11.79 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
11.79 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
11.79 | 17994277 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
5.32 | 7506515 |
MESH:D005532 |
Foot Deformities, Congenital |
|
methyl cellosolve |
4.98 | 3652986 |
MESH:D005739 |
Gas Poisoning |
|
Budesonide |
5.39 | 20016425 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.41 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.76 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
11.06 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
11.06 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Phenytoin |
5.14 | 9029455 |
MESH:D019214 |
Gingival Overgrowth |
|
Phenytoin |
5.69 | 14659971 16390469 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
6.31 | 17162496 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.31 | 17312396 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.55 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.05 | 10696789 |
MESH:D006130 |
Growth Disorders |
marker/mechanism |
|
| |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
6.60 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
6.60 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.62 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
nitrofen |
9.56 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.56 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
9.56 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
6.87 | 11110106 |
MESH:D006331 |
Heart Diseases |
|
Urethane |
6.87 | 16046796 |
MESH:D006345 |
Heart Septal Defects, Ventricular |
|
methyl cellosolve |
5.25 | 6499821 |
MESH:D006402 |
Hematologic Diseases |
|
2-ethoxyethanol |
4.90 | 20172899 10514026 |
MESH:D006461 |
Hemolysis |
|
2-ethoxyethanol |
10.55 | 19051582 17874071 |
MESH:D006461 |
Hemolysis |
|
methyl cellosolve |
10.55 | 17874071 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.92 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.86 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Thioacetamide |
4.10 | 18665440 17276928 15929193 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
12.83 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
12.83 | 19110552 19900420 |
MESH:D006505 |
Hepatitis |
|
Thioacetamide |
12.83 | 16456712 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 15340226 16120746 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
marker/mechanism |
|
| 10370016 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
5.72 | 7520565 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
nitrofen |
5.72 | 16490937 16863852 15136996 10898222 11329586 10646786 10898224 16292651 15088113 17270546 9859898 7576705 15185205 15764645 15756563 15707848 11076806 11685700 18280292 10359170 12194112 9473106 17245593 10541330 12759764 9575882 7760232 11051153 18958481 17618886 12407540 10370017 15793718 9476886 16720372 18280291 12505043 16473863 15578192 16080930 9698600 12746050 7520565 12547725 12021965 11588001 11584395 10370016 11409163 10693666 12904592 8863223 11057544 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.49 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.66 | 16876885 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
5.11 | 17019078 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.72 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.22 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.51 | 8697196 16354765 15340226 18606429 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Freund's Adjuvant |
6.96 | 16769263 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.96 | 16870215 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
4.77 | 17019078 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.00 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.54 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.05 | 16778211 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Phenytoin |
4.22 | 10459572 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.55 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
9.12 | 15034207 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
9.12 | 12960047 14722030 |
MESH:D006973 |
Hypertension |
|
Cobalt |
10.57 | 17039479 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
10.57 | 17042910 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
10.57 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
10.57 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.57 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.84 | 17488730 |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
4.20 | 12002444 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
5.66 | 17426086 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
9.53 | 16002989 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
9.53 | 16569931 16945680 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
5.32 | 7506515 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.13 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.85 | 15036965 |
MESH:D007247 |
Infertility, Female |
|
2-ethoxyethanol |
8.78 | 6499823 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
8.78 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
2-ethoxyethanol |
21.65 | 6499823 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
21.65 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
21.65 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
methyl cellosolve |
21.65 | 3987992 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
21.65 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
21.65 | 16467254 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
23.40 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
23.40 | 18785209 |
MESH:D007249 |
Inflammation |
|
Freund's Adjuvant |
23.40 | 16793879 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
23.40 | 17963957 17237260 9205823 12878042 17255318 |
MESH:D007249 |
Inflammation |
|
polyphenols |
23.40 | 16366677 |
MESH:D007249 |
Inflammation |
|
resveratrol |
23.40 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
23.40 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
23.40 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.01 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
6.24 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.24 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.26 | 17994277 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.14 | 17255318 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.48 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.36 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.36 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.04 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.04 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
14.25 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
14.25 | 16762066 15003126 14681315 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
14.25 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
14.25 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.51 | 16316344 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.55 | 17184923 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.01 | 16973256 |
MESH:D007938 |
Leukemia |
|
decitabine |
5.47 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
5.47 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
7.99 | 17236224 19117987 18454857 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
7.99 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.57 | 17679729 18460780 19010910 19387464 18206229 18704418 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.57 | 19850784 16294345 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
4.92 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
6.57 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
6.57 | 17107899 19225113 16891316 16935935 16788101 19029980 17339181 15748426 9834237 16140955 17712046 17368321 19075265 17301526 17361223 17217047 19035177 16766008 19642359 12679006 17294898 16331271 16823087 17506722 17649720 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.17 | 15821434 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.20 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
methyl cellosolve |
7.28 | 6499821 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
7.28 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.77 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
5.57 | 16943688 16221502 11408273 17174718 17157831 11903743 16239168 17334410 21278145 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
5.57 | 18665156 19638242 20032147 18407596 18522880 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.85 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
13.94 | 17805973 15362042 16136751 15123356 15370692 17525996 18472332 18418968 15925388 17976157 15931870 18263696 18210741 16033810 17900296 17766677 16015684 18166357 14748882 18481824 17708605 15959796 14716496 12445421 12898905 13678700 12632514 12609069 17761835 17565644 17698563 18395095 12666154 17944888 18277467 18705752 12649538 15057751 14620537 16116963 18472094 18420326 16638106 12958196 18376398 17631135 15730626 12632512 17922224 16192424 12546737 16097048 18395914 14724832 17557913 16011737 17714472 18156304 17869086 14716833 15818738 15893842 18412020 15876570 17823541 15052691 15673190 15650968 18251166 12667390 17481882 11481614 18006644 20821823 12389079 18317297 16248980 18187930 15338365 17640975 18054572 18339082 14512876 12741479 12445418 18429990 18279442 18205269 10355542 17721639 15996030 12586293 16027843 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
13.94 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
13.94 | 16169303 18637143 17198567 14726149 16009107 17203207 18239293 15369754 15571005 14643895 15577212 15591649 17724770 16603200 15763062 15744066 14659978 16627068 17432682 15723089 17465448 15161499 15479170 15793283 16270385 15504291 15081153 14568256 17881167 18629640 12918455 17534399 18210741 15383259 15138612 17201889 18364076 18567088 17640959 16570917 16544323 14709902 16042886 18237412 17719030 15942678 18095165 15492853 17036385 15733078 18371158 15842777 17348192 15339415 17666798 15864749 18672772 15067225 12925901 17196135 15099470 15086199 15798949 15366600 15298665 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
13.94 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
13.94 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
13.94 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
13.94 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thioacetamide |
13.94 | 16098781 15095483 16097051 17355460 18416461 15716488 12085344 15288472 12679928 16248980 18263696 15474484 14739098 11682029 12891558 15158331 15362042 15316131 12175628 18380797 17127702 18032466 15075984 18458672 17050028 16126171 15288473 18031379 18606216 11172339 12531686 17629604 10677585 15078482 18395095 17292413 15334695 16343077 11481614 18295389 16489207 12557150 15465738 16511523 18615449 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
13.94 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
10.75 | 17285989 16246199 16964402 15830285 15720792 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
10.75 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenytoin |
10.75 | 14986274 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
10.75 | 16698588 |
MESH:D008107 |
Liver Diseases |
|
Thioacetamide |
10.75 | 16337175 18374380 15158337 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.65 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
13.75 | 14706259 16899240 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
13.75 | 17457977 |
MESH:D017114 |
Liver Failure, Acute |
|
Thioacetamide |
13.75 | 15633222 17276928 12479984 15313186 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
25.56 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
25.56 | 2862719 19812893 19833225 18648771 18978307 20137499 20118626 21278145 19642983 19638242 19551842 19254457 2422723 12771043 21047994 19690152 21167192 18977376 21071580 19294768 20501860 20452335 20405173 19499222 20492335 18754104 10737359 20101389 19427195 18644402 16942905 15175105 19073162 12112319 19090486 19426721 19256749 19996281 9163691 19255062 20434301 15885732 19850985 20583210 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
25.56 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
25.56 | 15890375 3113478 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
25.56 | 20405173 19321006 19073162 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
25.56 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
25.56 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
25.56 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
Urethane |
25.56 | 17093202 17559639 16391232 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
22.99 | 6587162 598648 1399818 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
22.99 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dichloroacetate |
22.99 | 8973603 15036762 7955063 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
22.99 | 17174075 18775883 18308698 18544905 3124819 16267830 18164116 19009564 17942915 19539802 16842330 18079962 19004024 18282651 19126423 21159647 18093689 17854601 18253720 19519916 2563599 9362446 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
22.99 | 15603536 6150874 1848544 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
22.99 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Trichloroacetic Acid |
22.99 | 15036762 8973603 |
MESH:D008171 |
Lung Diseases |
|
nitrofen |
6.68 | 17245593 9859898 9614859 16863852 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.68 | 19095001 |
MESH:D008173 |
Lung Diseases, Obstructive |
|
Cobalt |
5.35 | 6434250 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.50 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
18.43 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Budesonide |
18.43 | 16885199 12117777 17163412 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
18.43 | 11195469 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
18.43 | 20970405 6695378 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
18.43 | 16061637 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
18.43 | 16712894 17077188 17306315 15276417 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
18.43 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
18.43 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
tipifarnib |
18.43 | 16885199 |
MESH:D008175 |
Lung Neoplasms |
|
Urethane |
18.43 | 11544531 12117781 16289808 17093202 17255336 11062179 15166089 11497255 11807781 11074608 10997738 11552296 11992545 7750092 12765245 16391232 16926031 15136453 11323394 16788158 10822126 10530776 11893704 11307925 12957351 14587096 15902970 16007126 16204055 17195641 12466968 11246140 6695378 16337739 10779650 |
MESH:D008175 |
Lung Neoplasms |
|
vinyl carbamate |
18.43 | 15172992 17163412 11134547 14755239 17361011 16885199 12438228 11195469 15824018 17363558 16247444 12117777 12765245 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.62 | 15166399 |
MESH:D008223 |
Lymphoma |
|
decitabine |
6.45 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
6.45 | 15700306 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.81 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.44 | 14749477 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.63 | 11161223 |
MESH:D008231 |
Lymphopenia |
|
methyl cellosolve |
5.25 | 3699323 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.98 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
8.25 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
8.25 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
15.11 | 19196723 15591091 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
15.11 | 11408345 11807958 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
15.11 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
15.11 | 16827153 14580682 19196722 11731420 19196723 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
tipifarnib |
15.11 | 16648579 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
10.86 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
10.86 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.55 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
8.49 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
resveratrol |
8.49 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
8.49 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
8.49 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
8.49 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.65 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.91 | 16940565 |
MESH:D008607 |
Mental Retardation |
|
Phenytoin |
3.47 | 9212184 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.90 | 17112576 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.01 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
14.15 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
14.15 | 16118317 15867202 15744524 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
14.15 | 16497877 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
14.15 | 14749477 16490592 17164350 17049120 16267019 17935668 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.34 | 17962980 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
10.53 | 16882708 19157545 18608210 19010910 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
10.53 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
10.53 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
2.79 | 17125593 16525036 16456233 17188708 16317513 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.61 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.61 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
2.87 | 16810080 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.23 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenytoin |
4.99 | 17484760 |
MESH:D009224 |
Myotonia Congenita |
|
Phenytoin |
4.88 | 1896199 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.01 | 16343187 |
MESH:D009336 |
Necrosis |
|
2-ethoxyethanol |
4.82 | 20172899 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
8.06 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
8.06 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
8.06 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.32 | 19410462 |
MESH:D009369 |
Neoplasms |
|
decitabine |
12.72 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
12.72 | 15313581 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
12.72 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
12.72 | 16946489 16594593 |
MESH:D009369 |
Neoplasms |
|
Urethane |
12.72 | 15625555 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
12.46 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
12.46 | 20056578 |
MESH:D009374 |
Neoplasms, Experimental |
|
Urethane |
12.46 | 15582191 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
9.15 | 19196722 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
9.15 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.21 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
25.44 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
25.44 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
25.44 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
25.44 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
25.44 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
14.43 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Phenytoin |
14.43 | 9118846 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
14.43 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
14.43 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.09 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.09 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
3.91 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.58 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
2.96 | 4026338 6482804 |
MESH:D009845 |
Oligospermia |
|
2-ethoxyethanol |
9.63 | 20172899 |
MESH:D009845 |
Oligospermia |
|
methyl cellosolve |
9.63 | 3987992 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.48 | 3988306 |
MESH:D010018 |
Osteomalacia |
|
Phenytoin |
4.88 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
6.39 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
6.39 | 19059307 17882678 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
8.59 | 17823083 15579764 17893378 15758505 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
8.59 | 17513867 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.46 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
12.89 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
12.89 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
12.89 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
12.89 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
Urethane |
12.89 | 16391232 |
MESH:D010146 |
Pain |
|
Phenytoin |
5.76 | 15215642 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.76 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
7.36 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
7.36 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
7.36 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.20 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
2.97 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.71 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.93 | 6228378 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.63 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
10.42 | 15687265 16977796 |
MESH:D010911 |
Pituitary Neoplasms |
|
Urethane |
10.42 | 16391232 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.03 | 12224865 11605937 |
MESH:D017689 |
Polydactyly |
|
Phenytoin |
4.59 | 9212184 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.06 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.11 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.23 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
2-ethoxyethanol |
37.48 | 7198755 6499817 2884743 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
37.48 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
37.48 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
methyl cellosolve |
37.48 | 7974496 6499817 12530607 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
37.48 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
37.48 | 11118676 11399792 11896295 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
37.48 | 19015723 18220299 18042343 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.21 | 17616702 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.41 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
15.31 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
15.31 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
15.31 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.29 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cholecalciferol |
2.29 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
2.29 | 15846301 15046698 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.29 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.29 | 16220300 16536755 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.29 | 16731767 17804756 17718901 17675339 15767336 17636462 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.29 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.29 | 15067354 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.41 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.12 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.79 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Phenytoin |
5.00 | 8603615 1419762 12752131 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.26 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.26 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cobalt |
3.78 | 6434250 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.01 | 15770314 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.04 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
2.99 | 16314181 15827377 17058453 16317513 17520802 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
3.53 | 11700416 18379247 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.37 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.33 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
2.98 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
9.33 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.33 | 16283617 16116481 |
MESH:D012640 |
Seizures |
|
Phenytoin |
3.39 | 10029267 3691417 15946322 16876388 3137016 9844417 11044598 19919933 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
5.66 | 16631401 |
MESH:D056730 |
Silver-Russell Syndrome |
marker/mechanism |
|
| 19066168 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
15.03 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
15.03 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
15.03 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
15.03 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Urethane |
15.03 | 11807781 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
17.02 | 16002989 16709447 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
17.02 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
17.02 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.51 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.38 | 12854658 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
4.73 | 12587719 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Phenytoin |
4.64 | 20235791 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.80 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
4.20 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.20 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
4.20 | 16033868 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.20 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
2-ethoxyethanol |
6.32 | 6499799 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
6.32 | 15138204 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.40 | 16837676 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.02 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.46 | 16684133 16045194 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
4.71 | 17997062 |
MESH:D013733 |
Testicular Diseases |
|
2-ethoxyethanol |
9.32 | 6499806 10514026 10048760 |
MESH:D013733 |
Testicular Diseases |
|
methyl cellosolve |
9.32 | 6499806 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.71 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.13 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.71 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.36 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
13.77 | 6587162 6582329 7505956 3712494 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
13.77 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
13.77 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
13.77 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
11.92 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
11.92 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.38 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.38 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.88 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
16.81 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
16.81 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
16.81 | 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
16.81 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
16.81 | 17306315 11723127 16712894 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
16.81 | 16712894 17572228 8653321 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
18.87 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
18.87 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
18.87 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
18.87 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
12.02 | 14652134 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
12.02 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
13.18 | 15809267 16690809 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
13.18 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
13.18 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
11.04 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
11.04 | 16752155 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
4.28 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
3.92 | 16002989 16513791 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.90 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.05 | 12125929 |
MESH:D019043 |
Vascular Neoplasms |
|
Urethane |
5.37 | 10620525 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.67 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.07 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.79 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.56 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.01 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.71 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.52 | 16287080 |
MESH:D014947 |
Wounds and Injuries |
|
Estrogens |
4.31 | 11172683 |